With the EU’s 2018 General Data Protection Regulation (GDPR), the California Consumer Privacy Act (CCPA), which became effective January 2020,
Continue Reading Keeping Privacy in Mind in the Early Stages of Your Company
SBIR Policy Directive Update Preserves Government Contracting Benefits in Acquisition
The policy directive for the Small Business Innovation Research and Small Business Technology Transfer programs (collectively, “SBIR”) was updated,
Continue Reading SBIR Policy Directive Update Preserves Government Contracting Benefits in Acquisition
Is SBIR a Fit for Your Company?
The Small Business Innovation Research (“SBIR”) program provides funding that start-ups can use to develop and de-risk products without diluting
Continue Reading Is SBIR a Fit for Your Company?
Scribe Enters CRISPR-Based Collaboration with Biogen
On October 7, 2020, Scribe Therapeutics announced a collaboration with Biogen, to collaborate on CRISPR-based medicines for treating neurological
Continue Reading Scribe Enters CRISPR-Based Collaboration with Biogen
How to protect your mark internationally? Considerations on the Madrid System
Nowadays, the concept of business can rarely prescind from globalization. But the rules and regulations that provide Intellectual Property protection
Continue Reading How to protect your mark internationally? Considerations on the Madrid System
Aledia, French microLED Startup, Announces €80M First Tranche Close on €120M Round
French microLED display startup Aledia announced it closed an €80M first tranche of its €120M D-round financing. The company will
Continue Reading Aledia, French microLED Startup, Announces €80M First Tranche Close on €120M Round
Critical Steps for Building Winning Patent Portfolios
Leaders of emerging companies must make many critical decisions at the outset of their company’s growth cycle, not the least
Continue Reading Critical Steps for Building Winning Patent Portfolios
A2 Biotherapeutics Closes $70+M Series B Round to Fund Cancer-Fighting Tmod Platform
Cambridge Startup Walden Biosciences Launches With $50M Raise
Cambridge startup biotechnology company Walden Biosciences announced its launch today with a $51 million Series A financing led by UCB
Continue Reading Cambridge Startup Walden Biosciences Launches With $50M Raise